Use of a Subcutaneous Catheter for Controlled Ovarian Stimulation

Status unconfirmed

Conditions studied: Infertility, Female

In brief

Subcutaneous medications are an integral part of controlled ovarian stimulation protocols for in-vitro fertilization (IVF), but daily or twice daily injections are both physically and emotionally burdensome for patients and their partners. This is a feasibility study to evaluate the use of the Neria Guard™ (Unomedical, Convatec) subcutaneous catheter for ovarian stimulation in IVF.

Key facts

Study ID

NCT05505474

Run by

University of Southern California

People needed

100

Starts

2023-11-02

Expected to finish

2024-12-31

Last updated by the study team

2023-11-18

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Female between 18 and 45 years of age undergoing controlled ovarian stimulation

You may not qualify if…

• none

Where it is running

• HRC Fertility — Los Angeles, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.